Benzodiazepines and Other Targeted Substances Regulations

Marginal note:Prescription required

• 51 (1) In addition to the activities authorized under section 55, a pharmacist may, subject to section 52, sell, provide, send, deliver or transport a targeted substance to or for an individual or for the benefit of an animal if

  • (a) the pharmacist sells or provides the substance in a container labelled in accordance with subsection (2);

  • (b) the transaction is made pursuant to a prescription

    • (i) dated and signed by a practitioner,

    • (ii) provided verbally to the pharmacist by a practitioner, or

    • (iii) transferred to the pharmacist under subsection 54(1) in accordance with subsection 54(2);

  • (c) the pharmacist has not transferred the prescription to another pharmacist; and

  • (d) where the transaction has been provided verbally, the transaction is recorded by the pharmacist in accordance with subsection (3).

• Marginal note:Labelling required

  (2) A pharmacist who sells or provides a targeted substance to an individual must do so in a container that is labelled with the following information:

  • (a) the name and address of the pharmacy or pharmacist;

  • (b) the date of issuance of the prescription and the number given to it by the pharmacist;

  • (c) the name of the individual or animal for whose benefit the targeted substance is sold or provided;

  • (d) the name of the practitioner who issued the prescription;

  • (e) the specified name or brand name of the targeted substance;

  • (f) the quantity and, if applicable, the strength per unit of the targeted substance; and

  • (g) the directions for use specified by the practitioner.

• Marginal note:Record of verbal prescription

  (3) A pharmacist who receives a verbal prescription for a targeted substance must, before filling it,

  • (a) record the following information:

    • (i) the name and address of the individual or animal for whose benefit the prescription is provided,

    • (ii) the date that the verbal prescription was provided,

    • (iii) the specified name or brand name of the targeted substance, as specified in the prescription,

    • (iv) the quantity and, if applicable, the strength per unit of the targeted substance,

    • (v) the name of the recording pharmacist and the name of the practitioner who issued the prescription,

    • (vi) the directions for use specified by the practitioner, and

    • (vii) if the prescription is to be refilled, the number of times it may be refilled and, if specified, the interval between refills; and

  • (b) must keep a hard copy or create a written record of the prescription.